ANTX
ANTX clinical trials: AN2 Therapeutics, Inc.
Every trial on ClinicalTrials.gov where AN2 Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 8
- Trials linked
- 7
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ANTX on the catalyst calendar · ANTX registry changes
- Primary completion Apr 2029Sponsor estimatePhase 2NCT07891533Phase 2 Study of Oral Epetraborole in Adults With Polycythemia VeraAN2 Therapeutics, Inc · Polycythemia Vera (SNOMED CT: 109992005)Not yet recruitingANTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 18, 2024ActualPhase 2/Phase 3NCT05327803Study of Epetraborole in Patients With Treatment-refractory MAC Lung DiseaseAN2 Therapeutics, Inc · MAC Lung DiseaseTerminatedANTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 14, 2026ActualPhase 1NCT07024589First-in-Human Trial of Oral AN2-502998AN2 Therapeutics, Inc · Healthy VolunteersCompletedANTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 31, 2024ActualNo phase registeredNCT06089668An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed MelioidosisAN2 Therapeutics, Inc · MelioidosisCompletedANTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 26, 2022ActualPhase 1NCT04892641Phase 1 Study of Epetraborole TabletsAN2 Therapeutics, Inc · Healthy VolunteersCompletedANTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 26, 2023ActualPhase 1NCT05995444A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult SubjectsAN2 Therapeutics, Inc · Healthy VolunteersCompletedANTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 10, 2022ActualPhase 1NCT05283746A Study of Epetraborole Tablets in Subjects With Degrees of Renal FunctionAN2 Therapeutics, Inc · Renal InsufficiencyCompletedANTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 2NCT07301320Epetraborole in Patients With Mycobacterium Abscessus Lung DiseaseKevin Winthrop · Mycobacterium Abscessus InfectionRecruitingANTXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 8 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner